Abstract
Abstract
 Tuttha Bhasma (TB) is an important metal based drug used in Ayurveda. It has widespread therapeutic uses in the treatment of metabolic disorders. Despite of its therapeutic utility there is a lack of data related to its safety. Hence the present study was undertaken to evaluate chronic toxicity of TB in Wistar albino rats. Chronic toxicity study was conducted as per AYUSH guidelines 170 and the parameters such as ponderal changes; biochemical, hematological and histopathological examinations were recorded. Based on the overall toxicity profile significant changes in the serum SGPT was noted in therapeutic and higher dose levels. We could see the serum cholesterol, SGOT, SGPT and albumin levels were significantly elevated at lower dose compared to the control group. Histopathology of kidney showed cell infiltration and sections from liver showed mild to moderate fatty changes at higher dose levels. Histopathology of jejunum revealed there was mild to moderate epithelial erosion and shortening of epithelial layer. However overall toxicity study parameters showed the test drug TB is well tolerated and no dose dependent toxicity symptoms were observed. Based on the findings we could conclude that Tuttha bhasma is much safer to use at therapeutic dose level. However, at higher dose levels there are chances of organ toxicity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
